United BioSource Corporation is pleased to introduce Bracket, a Specialty Services provider dedicated to helping pharmaceutical sponsors and contract research organizations (CROs) achieve greater certainty and accurate outcomes in their clinical trials. Bracket combines two existing UBC businesses: UBC's Clinical Technologies Group and Specialty Clinical Services business. The company's goal in operating these formerly distinct business units as one cohesive business is to leverage the integration of science, technology and operational excellence and expand our portfolio of specialty products so they can best help customers optimize their research and development activities.
Bracket will continue to offer its pre-approval specialty solutions, including e-Clinical Technologies such as IVRS, ePRO, and eLearning as well as comprehensive Endpoint Reliability Solutions that incorporate Rater Training, Endpoint Adjudication, Ratings Surveillance, and Computerized Cognitive Testing.
The alignment of this breadth of capability is designed to address the new paradigm in clinical development: one that demands tools and analytics to optimize decision-making and ultimately provide greater precision. Although operating under a new and distinct public brand, Bracket will remain a UBC company.